Epcoritamab-bysp (Epkinly) – A phenomenal breakthrough in the treatment of diffuse large B-cell lymphoma

Rare Tumors · Published 2023-04-01 · DOI 10.1177/20363613231193566

Authors being retrieved — see the publisher record. https://doi.org/10.1177/20363613231193566

Abstract

DOAJ holds no abstract for this record.

Read the article at the publisher →

Publication details

Year
2023

Related articles